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Abstract
Significant progress has been achieved toward elucidating the molecular mechanisms that underlie breast cancer
progression; yet, much less is known about the associated cellular biophysical traits. To this end, we use time-lapsed
confocal microscopy to investigate the interplay among cell motility, three-dimensional (3D) matrix stiffness, matrix
architecture, and transforming potential in a mammary epithelial cell (MEC) cancer progression series. We use a well
characterized breast cancer progression model where human-derived MCF10A MECs overexpress either ErbB2, 14-3-3f,o r
both ErbB2 and 14-3-3f, with empty vector as a control. Cell motility assays showed that MECs overexpressing ErbB2 alone
exhibited notably high migration speeds when cultured atop two-dimensional (2D) matrices, while overexpression of 14-3-
3f alone most suppressed migration atop 2D matrices (as compared to non-transformed MECs). Our results also suggest
that co-overexpression of the 14-3-3f and ErbB2 proteins facilitates cell migratory capacity in 3D matrices, as reflected in cell
migration speed. Additionally, 3D matrices of sufficient stiffness can significantly hinder the migratory ability of partially
transformed cells, but increased 3D matrix stiffness has a lesser effect on the aggressive migratory behavior exhibited by
fully transformed cells that co-overexpress both ErbB2 and 14-3-3f. Finally, this study shows that for MECs possessing partial
or full transforming potential, those overexpressing ErbB2 alone show the greatest sensitivity of cell migration speed to
matrix architecture, while those overexpressing 14-3-3f alone exhibit the least sensitivity to matrix architecture. Given the
current knowledge of breast cancer mechanobiology, these findings overall suggest that cell motility is governed by a
complex interplay between matrix mechanics and transforming potential.
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Introduction
The vast majority of breast cancer-related deaths result
from metastatic tumors; thus, understanding the interplay
between the cellular microenvironment and breast cancer
metastatic potential is critically important to the development
of effective treatments for this disease. Significant progress has
been achieved toward revealing the molecular mechanisms that
underlie breast cancer progression [1,2]; however, quantitative
characterization of the associated cellular biophysical attri-
butes remains incomplete. Fundamentally, metastasis proceeds
via the migration and invasion of cancer cells through variable
extracellular matrix (ECM) environments, and studies have
shown that cell migration is indeed sensitive to matrix
mechanical properties [3,4,5]. Yet, the systems level relationships
among matrix mechanics, disease progression, and cell motility
in breast cancer are not well understood, especially with res-
pect to physiologically relevant three-dimensional (3D) matrix
environments.
Over the past two decades, key breast cancer biomarkers have
been identified and linked to specific stages of the disease. Two
notable factors are the ErbB2 (HER2/neu) and 14-3-3f proteins,
both of whose overexpression has been correlated with poor
clinical prognoses of breast cancer patients [6,7]. ErbB2 and 14-3-
3f have been similarly shown to induce cellular features in
vitro that are comparable to clinical presentations. ErbB2 is a
transmembrane receptor tyrosine kinase of the epidermal growth
factor receptor family of proteins and is involved in multiple
signaling pathways that modulate cell growth, differentiation,
apoptosis, and other critical cellular processes [8]. Analogously,
MECs that are engineered to overexpress ErbB2 have been shown
to exhibit hyperplasia and luminal filling in 3D culture, though not
full transformation and invasion [9,10]. ErbB2 is undoubtedly one
of the most studied molecules in the field of breast cancer [11] and
is a critical target for drug development. In fact, given its ability to
confer resistance to certain types of cancer therapy and its
prognostic value, determining its status with respect to newly
diagnosed breast cancer cases has become a standard practice
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e20355[12]. Strikingly, the ErbB2 protein is overexpressed in over 50% of
early stage non-invasive breast cancers (ductal carcinoma in situ,
DCIS) [13]; yet, it is overexpressed in only approximately 25% of
later stage invasive and metastatic breast cancers [7]. Explanation
of these seemingly inconsistent ErbB2 expression profiles has
eluded researchers to date; however, the results reported here
suggest that this phenomenon may be explained in part by a
mammary epithelial cell (MEC) sensitivity to matrix architecture.
The 14-3-3f protein belongs to a larger family of seven 14-3-3
regulatory proteins that are widely expressed and involved in a
variety of cellular homeostatic processes, including a general cell
survival/anti-apoptotic mechanism [14]. It has been shown that
overexpression of 14-3-3f confers MECs in 3D culture with a
significant resistance to anoikis [15] (a type of apoptosis that occurs
when epithelial cells detach from extracellular ligands), which
promotes luminal filling and drives MECs towards transformation
[16]. Overexpression of 14-3-3f has also been shown to induce
notable morphological features of epithelial-mesenchymal transi-
tion, which are characteristic of progression towards an invasive
phenotype [9,15,17]. Moreover, analyses of patient biopsies
indicate that over 40% of metastatic breast cancers overexpress
this protein [6]. Despite their abilities to bestow non-transformed
cells with oncogenic attributes, overexpression of neither ErbB2
nor 14-3-3f alone is sufficient to confer a complete transformation
in vitro. However, their cooperative overexpression has been
shown to promote progression from non-invasive carcinoma to
invasive cancer in vitro and is also associated with progression of
DCIS to invasive and metastatic breast cancer in patients [9].
Given previously established correlations between breast cancer
biomarkers and metastatic progression, as well as the current
knowledge of substrate-dependent cell motility and cell-matrix
interactions, the following fundamental questions remain unan-
swered for individual MECs with respect to matrix mechanics: (1)
Is MEC motility responsive to 3D matrix stiffness? (2) Is this
responsiveness related to transforming potential? And (3), is there a
relationship between cell motility and transforming potential,
given a determined matrix architecture? In this study, we
quantitatively investigated these questions by employing time-
lapsed confocal microscopy to investigate the effect of matrix
stiffness and architecture on migration speed and persistence of
individual MECs that are cultured atop 2D matrices and those
that are embedded within 3D matrices of differing elastic moduli.
We examined human-derived MECs of varied transforming
potential with respect to matrices formulated from native Type I
collagen, which is the primary structural component of the
mammary stroma. Our studies provide novel insights into breast
cancer mechanobiology by demonstrating that matrix stiffness and
architecture couple with transforming potential to govern the
migratory capabilities of MECs.
Results
In order to explore the relationships between breast cancer
transforming potential and cell motility with respect to matrix
mechanics, we analyzed a well characterized cancer progression
series established from the non-transformed, human-derived
MCF10A cell line. We examined four MCF10A sublines, whose
extent of transforming potential is characterized according to their
growth traits and morphological features when forming acinar
structures in 3D culture [9]. As described previously [9,17], the
sublines (Fig. 1A) consisted of [1] 10A.vec—a non-transformed
control cell line, [2] 10A.ErbB2—a hyperplastic, apoptosis-
resistant partially transformed cell line that overexpresses ErbB2,
[3] 10A.14-3-3f—a depolarized, apoptosis-resistant, and morpho-
logically abnormal partially transformed cell line that overexpress-
es 14-3-3f, and [4] 10A.ErbB2.f—an invasive, fully transformed
cell line that overepxresses both ErbB2 and 14-3-3f.
Effect of transforming potential on cell motility atop 2D
matrices
Cell motility was first examined with respect to the 2D matrix
architecture, which is analogous to the MEC layer that lines the
inner surface of the ductal basement membrane at the initial stage
of invasion into the underlying collagen I-rich stroma in vivo
(Fig. 1A). In this environment, MECs overexpressing ErbB2 alone
migrated with the fastest average migration speed ,S. (Fig. 1B).
Non-transformed cells exhibited the second highest degree of
motility, followed by sublines overexpressing 14-3-3f (Fig. 1B).
Two-dimensional motility patterns of partially transformed and
fully transformed cells are also consistent with transwell motility
behavior that has been reported previously: 10A.ErbB2 cells
moved with the highest speeds, followed by 10A.ErbB2.f and then
by 10A.14-3-3f [9]. Persistence time P (obtained from curve fitting
to the persistent random walk model [18], see Materials and
Figure 1. MCF10A cell motility atop 2D matrices. (A) Ductal/single lobe cross-sectional depiction of MCF10A breast cancer progression series:
10A.vec (non-transformed), 10A.ErbB2 (partially transformed), 10A.14-3-3f (partially transformed), and 10A.ErbB2.f (fully transformed). (B) Mean cell
migration speed ,S. atop 2D matrices; p-values are with respect to ,S. of 10A.vec cells. (C) Cell population persistence time P atop 2D matrices
(average R=0.87). All p-values (*,p#0.05; **, p#0.01; ***, p#0.001) determined from t-tests for unpaired samples.
doi:10.1371/journal.pone.0020355.g001
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sublines possessing transforming potential (Fig. 1C).
Effect of transforming potential on cell motility within 3D
matrices
Next, cell motility was assessed with respect to the 3D matrix
architecture, which is analogous to the in vivo environment where
genetically altered (partially or fully transformed) cells have
invaded their local basement membrane and penetrated into the
underlying stroma (Fig. 1A). Cell motility assays showed that
transforming potential had a notable effect on migration speed
,S. within relatively compliant 3D matrices (Fig. 2A, stiffness
G
9
c=104 Pa). Non-transformed MECs (10A.vec) exhibited
the slowest average speed, whereas fully transformed MECs
(10A.ErbB2.f) migrated with the fastest speed (Fig. 2B). MECs
overexpressing ErbB2 or 14-3-3f alone, although partially
transformed, did not show a notable change in motility rela-
tive to 10A.vec cells (Fig. 2B) in compliant 3D matrices.
Furthermore, migration speed ,S. in compliant matrices
negatively correlated with the sphericity cell morphology index
Y that we previously reported of these sublines when cultured in
the same 3D matrices [17]. As shown in Fig. 2B (inset) [17], Y
decreases as ,S. increases, according to MEC transformation
profile. In compliant matrices, cell population persistence time P
was lowest for fully invasive cells (Fig. 2E).
Effect of 3D matrix stiffness on cell motility
In relatively stiffer 3D matrices (Fig. 2A, stiffness G
9
c=391 Pa),
cell motility assays revealed a behavior significantly different from
that observed in compliant matrices. In the stiffer matrix
environment, fully transformed MECs migrated faster than all
other sublines (Fig. 2C). However, partially transformed cells
(10A.ErbB2 and 10A.14-3-3f) migrated notably slower than both
non-transformed and fully transformed cells. The shift in cell
motility between compliant and stiff matrices is further displayed
as a percent decrease in migration speed, according to transfor-
mation profile (Fig. 2D); this depiction shows that among the
sublines whose migration speed was sensitive to 3D matrix
stiffness, the motility of fully transformed cells was least affected
by the increase in matrix stiffness. As compared to cells in
Figure 2. MCF10A cell motility in 3D matrices. (A) Scanning electron micrographs of compliant (104 Pa) and stiff (391 Pa) 3D matrices; scale bar
is 2 mm. (B) Mean cell migration speed ,S. in compliant 3D matrices. (Inset) cell sphericity Y as taken from Baker et al. [17]; p-values are with respect
to ,S. (and Y) of 10A.vec cells. (C) Mean cell migration speed ,S. in stiff 3D matrices; p-values are with respect to ,S. of 10A.vec cells. (D)
Percent decrease in ,S. of cells within compliant matrices relative to cells in stiff matrices. The p-values shown in black reflect the difference in ,S.
between cells within compliant matrices and the same cells within stiff matrices; the p-values shown in red reflect the difference in % decrease in
,S. among the sublines. (E) Cell population persistence time P in compliant and stiff 3D matrices (average R=0.87). (F) Percent decrease in ,S. of
cells atop 2D matrices relative to cells within compliant 3D matrices. The p-values shown in black reflect the difference in ,S. between cells atop 2D
matrices and the same cells within compliant 3D matrices; the p-values shown in red reflect the difference in % decrease in ,S. among the sublines.
All p-values (*,p#0.05; **, p#0.01; ***, p#0.001) determined from t-tests for unpaired samples.
doi:10.1371/journal.pone.0020355.g002
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(Fig. 2E) was lower for cells possessing partial or full transforming
potential, but notably higher for non-transformed cells (10A.vec).
Integrated effects of matrix architecture, matrix stiffness,
and transforming potential on cell motility
Comparing migration speeds of cells atop 2D matrices to those
embedded within similar 3D matrices shows that matrix
architecture has a significant effect on cell motility. Figure 2F
depicts this shift in motility as a percent decrease in speed of cells
atop 2D matrices as compared to those within compliant (104 Pa)
3D matrices. Indeed, motility in 3D matrices is significantly
reduced for all cell sublines examined; however, of the sublines
possessing partial or full transforming potential, cells overexpress-
ing ErbB2 alone (10A.ErbB2) showed the greatest sensitivity to
matrix architecture. The 10A.ErbB2 subline experienced a
significant 94% decrease (15-fold reduction) in cell migration
speed when in 3D matrices as compared to that when these cells
were attached to 2D matrices.
Examination of 3D Windrose plots (Fig. 3) provides a broad,
summary view of the migratory character exhibited by this
MCF10A progression series (rows represent matrix condition,
while columns represent subline). XY-plane confocal images
(Fig. 4) also show typical representative cells and morphological
featuresexhibited byeachofthe foursublines,which maybearsome
association to migratory data presented here, as well as cell stiffness
findings that we have reported previously [17]. MECs overexpress-
ing14-3-3faloneexhibitedtubular-shapedprotrusions(Fig.4,green
arrows) [19] across all matrix conditions, while those co-overex-
pressing both ErbB2 and 14-3-3f exhibited thin, rod-like extensions
(Fig. 4, yellow carats) for all matrix conditions. Cells overexpressing
ErbB2 alone showed minimal rod-like extensions and only when
embedded within relatively stiff (391 Pa) matrices, while the
remaining MEC sublines displayed similar degrees of protrusion
in both compliant and stiff matrices. The fastest migrating cells on
2D matrices (10A.vec and 10A.ErbB2) exhibited sheet-like cellular
processes in this environment (Fig. 4, blue brackets).
Discussion
Cell motility can be influenced by a number of parameters,
including extracellular chemical gradients [20], matrix mechan-
ical properties [4], matrix degradation [21], intracellular contrac-
tility [5], and cell adhesivity [22]. Increasingly, cancer cells have
become the focus of studies that explore the effect of the
extracellular environment on cellular homeostasis [4,23], cellular
viscoelasticity [24,25], and cell motility. While significant pro-
gress has been achieved in uncovering some of the molecular
mechanisms and signaling pathways that underlie breast and
other cancers [8,14], much less is known about the associated
cellular biophysical attributes. It has long been established that
Figure 3. Windrose plots of MCF10A cell migration. Top row lists cell line; left column lists matrix condition. Cells in 2D matrices exhibited the
highest degree of motility, followed by cells within compliant (104 Pa) 3D matrices and then by cells within stiff (391 Pa) 3D matrices.
doi:10.1371/journal.pone.0020355.g003
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migration from a primary tumor mass through the underlying
stroma and that breast collagen density is correlated with breast
cancer progression [26]. Moreover, cancer cell migratory
capability can be influenced by the stiffness of the ECM [5].
However, the relationship between the external cellular mechan-
ical environment and the motility of breast cancer cells is not
understood. The interplay between these parameters is further
confounded by the stage of breast cancer progression and may
also bear relation to intracellular mechanical properties [17]. In
order to investigate the interplay among matrix mechanics, cell
motility, and transforming potential in breast cancer, we have
utilized time-lapsed confocal microscopy to gauge the migration
speed and persistence of MECs that are attached to 2D matrices
and those that are embedded within 3D matrices, both comprised
of native Type I Collagen. By examining a breast cancer
progression series of sublines that derive from a single MEC
parent line, we are able to directly compare kinesis of cells that
possess varying transforming potential.
The in vivo extracellular microenvironment is a heterogeneous
medium that consists of several components, with the relative
balance and significance of these components depending upon the
extent of cancer progression. In this study, we have probed the
motility of MECs that have the capacity to freely navigate their
ECM. For the case of 3D matrices, this is physiologically most
comparable to individual MECs that have invaded their local
ductal basement membrane and may migrate within the
underlying stroma (Fig. 1A); for the case of 2D matrices, this is
most analogous to early stage cancer cells that may exhibit
enhanced motility along the inner ductal basement membrane at
the initial stage of invasion into the underlying collagen I-rich
stoma (Fig. 1A). We examined single cells that are wholly engaged
with the matrix (but unattached to other cells) in order to
experimentally control the degree and type of cell surface
attachment; thus, the MECs examined here form cell-matrix
attachments via b1 integrins [27].
Examining cell migration with respect to both 2D and 3D
matrices offers a broad perspective of MEC motility (Fig. 3).
Overexpression of ErbB2 has been shown previously to bestow
MECs with increased proliferative capacity [10], and it has also
been associated clinically with early stage breast cancer (DCIS)
[9]. In fact, the matrix environment of early stage breast cancers
(DCIS) more closely resembles that of a 2D matrix architecture
than it does a 3D matrix environment (Fig. 1A). When cultured
atop 2D matrices, MECs overexpressing ErbB2 alone migrated
with the fastest speed (Fig. 1B); non-transformed cells exhibited the
second highest degree of motility, followed by sublines overex-
pressing 14-3-3f (Fig. 1B). The significantly reduced migration
speed of 14-3-3f-overexpressing sublines relative to the remaining
two sublines suggests that 14-3-3f-mediated downregulation of
E-cadherin [9,15] may yield a lesser effect on cell motility atop 2D
matrices than on MECs that are tasked with navigating a 3D
matrix environment. This again underscores the complex
interplay between transforming potential and matrix mechanics
in governing cell motility. High persistence of non-transformed
cells relative to the remaining genetically altered sublines (Fig. 1C)
indicates that transforming potential may grant MECs with a
heightened sensitivity to 2D matrix topography, which would be
reflected in randomly changing cell trajectories as compared to
more directed cell movements of non-transformed cells. An
increased sensitivity to matrix topographical cues should be
advantageous to cells that seek to invade their local basement
membrane.
Our results suggest that within relatively compliant 3D matrices
(104 Pa), transforming potential in association with morphological
features are the dominate factors that influence cell motility. As
shown in Fig. 2 B, fully transformed cells (10A.ErbB2.f) migrated
with the fastest speed ,S. in this environment, followed by
morphologically altered 14-3-3f-overexpressing cells, and 19]. As
displayed in Fig. 4, 3D tubular protrusive structures are evident in
both sublines that overexpress 14-3-3f. Several previous studies
indicate that this morphological phenotype is mediated by
Figure 4. Single-plane confocal images of MCF10A cells embedded within 3D Type I collagen matrices and cultured atop 2D Type I
collagen matrices. Top row lists cell line; left column lists matrix condition. Yellow carats indicate thin, rod-like cellular processes. Green arrows
indicate tubular-shaped cellular protrusions. Blue brackets indicate sheet-like cellular protrusions.
doi:10.1371/journal.pone.0020355.g004
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mechanical integrity to epithelial tissues by anchoring epithelial
cells to one another along the basement membrane. Knockdown
of E-cadherin function thereby disrupts cell polarity and
characteristically round morphological phenotypes [9,15]. There-
fore, the motility results reported here (Fig. 2B), taken with our
previously reported sphericity data [17], underscore prior
investigative conclusions that 14-3-3f is a negative effector of
E-cadherin [9,15]. Examination of cell persistence time P in
compliant matrices (Fig. 2E) indicates that fully transformed cells
navigate their environment in a much less directed manner
than do cells that only possess partial transforming potential
(10A.ErbB2 and 10A.14-3-3f). Again, this agrees with cell
morphological observations that reveal extended rod-like cell
surface protrusions on fully invasive cells (Fig. 4), which are known
to mediate surveillance of environmental gradients and steric
barriers imposed by matrix fibers [19].
Comparing MEC motility in compliant matrices to that of
MECs in stiffer matrices suggests that cell migratory ability is not
simply an effect of transforming potential; rather, it is governed by
a balance of intrinsic cell biophysical attributes along with matrix
mechanics. The slight enhancement of thin, rod-like extensions
exhibited by 10A.ErbB2 cells in stiffer matrices (Fig. 4), although
subtle, may bear association to the high stiffness sensing capability
that we have previously reported of this subline [17]. However,
although morphological features of a given subline were similar in
3D matrices of differing stiffness (Fig. 4), the system-wide
migration speed profiles show distinct patterns relative to matrix
stiffness (Fig. 2B and C and Fig. 3). In both matrix environments,
non-transformed MECs migrated more slowly than fully trans-
formed MECs, which migrated with the fastest speeds. However,
in the stiffer matrices (391 Pa), partially transformed cells
(10A.ErbB2 and 10A.14-3-3f) migrated significantly slower than
non-transformed cells. Increased matrix stiffness resulted in a
decreased migratory ability for fully transformed cells, but this
effect was even more pronounced for partially transformed cells
(Fig. 2D). These results suggest that sufficient density-dependant
3D matrix stiffness may play a role in significantly hindering the
migratory ability of partially transformed cells; however, this
increase in 3D matrix stiffness may not be ample to overcome the
aggressive behavior exhibited by fully invasive cells, as evidenced
by the only moderate reduction in migration speed of
10A.ErbB2.f cells (Fig. 2D). Results from our prior study of these
sublines showed that in the stiffer matrices, 10A.ErbB2 cells
exhibit the highest intracellular stiffness, while fully transformed
10A.ErbB2.f cells exhibit a moderate stiffness, and 10A.14-3-3f
cells exhibit a relatively low stiffness [17]. In total, considering the
current motility data in conjunction with the results of our
previous investigations suggests that MEC migration in 3D
environments proceeds at an optimal balance among genetic
transformation profile, intracellular stiffness, advantageous mor-
phological features, and matrix stiffness. Thus, an increase in cell
migratory speed that may otherwise result from partial or full
transformation may be mitigated in part by density-dependant
matrix stiffness.
The final analysis of this study (Fig. 2F) presents a very
provocative result, given that the ErbB2 oncogene is detected with
lower frequency in invasive and metastatic breast cancers than it is
in early stage breast cancers. In fact, the prevalence of ErbB2
overexpression in invasive and metastatic breast cancer is only half
that of early stage cancers [9], which has been a perplexing
phenomenon. The results from our motility assays suggest that a
shift in matrix architecture may be associated with this behavior.
When MECs transition from a non-invasive early stage cancer to
an invasive and then metastatic cancer, they migrate from atop a
2D basement membrane surface to within a surrounding 3D
stroma and thus experience a shift in matrix architecture (Fig. 1A).
In this study, the motility of 10A.ErbB2 cells shows the greatest
sensitivity to a shift in matrix architecture, as compared to the
other sublines that possess partial or full transforming potential
(Fig. 2F). It follows that cells exhibiting a significantly diminished
stromal migratory ability may be less likely to completely invade
their local boundaries and further traverse the surrounding stroma
to later manifest as metastatic breast cancer. It should also be
noted that overexpression of 14-3-3f significantly suppressed 2D
migration (Fig. 1B), while synergistically enhancing 3D migration
when ErbB2 was also overexpressed (Fig. 2B and C). Thus, the
motility of cells overexpressing 14-3-3f alone exhibited the least
sensitivity to matrix architecture, as compared to 10A.ErbB2 and
10A. ErbB2.f cells (Fig. 2F).
In summary, the present study provides novel insights into
breast cancer motility by demonstrating that transforming
potential couples with matrix stiffness and architecture to influence
the migration speed and persistence of MECs. Numerous prior
investigations have significantly contributed to the present
understanding by examining ErbB2 and 14-3-3f-mediated effects
on intracellular stiffness [17], MEC motility in soluble chemical
gradients [20], cancer cell migration with respect to ligand
availability [5], and motility-induced matrix remodeling [28]. By
employing time-lapsed imaging, we have added to this knowledge
by directly measuring the migration speed of MECs both cultured
atop 2D matrices and embedded within 3D matrices. The
relationships between breast cancer cell motility and substrate
characteristics are complex; further clarification of these connec-
tions may arise from additional future studies that examine the
effects of 2D matrix stiffness and matrix protein constitution on the
motility of the sublines examined here. A clearer understanding of
MEC-matrix interactions holds broad promise that may ultimately
direct the development of targeted therapies and cancer-focused
translational research.
Materials and Methods
Cell culture
Motility assays were performed on stable sublines that were
established as described previously [9] from the non-cancerous,
human-derived MCF10A MEC line (provided by Dr. Robert
Pauley of the Karmonos Cancer Institute, Detroit, MI). Cell lines
were maintained in 2D monolayer culture in DMEM/F12 growth
media [29] within a humidified incubator at 37uC, 5% CO2 until
the time of experimentation.
Collagen matrix preparation and characterization
Two-dimensional matrices were created by diluting high
concentration Type 1 collagen to 2 mg/mL using 20 mLo f
ethanol-dialized 2.0 mm carboxylated, yellow-green fluorescent
polystyrene tracer beads (Molecular Probes, Carlsbad, CA)
(approximately 2% solid) and a balance of 0.01 M HCl; 1.5 mL
of the solution was then deposited into the well of a 35 mm glass
bottom dish and allowed to incubate at room temperature for 1 h.
Following this period, the solution was aspirated, leaving only the
bead-impregnated collagen coat that had adhered to the glass
bottom (see Fig. S1 A). Dishes were then rinsed twice with PBS and
stored at 37uC, 5% CO2 for 45 min until fluorescently labeled cells
were deposited into the dish.
Three-dimensional matrices were formulated from high con-
centration Type I collagen (BD Biosciences, San Jose, CA), which
was diluted to two concentrations of 2 and 4 mg/mL. Equal parts
Mechanics and Transforming Potential in Migration
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pH 7.3) were mixed with 20 mL of the bead suspension and a
balance of 5610
5 fluorescently labeled cells suspended in growth
media to achieve the final concentration [30] (see Fig. S1 B). Each
matrix solution (1 mL) was then deposited across the surface of a
35 mm glass bottom dish (MatTek, Ashland, MA). Matrix
solutions were allowed to gel for 90 min at 37uC, 5% CO2, upon
which 1.5 mL of growth media were deposited atop the 3D
matrices to provide cells with adequate nutrients during a
subsequent 4.5 h incubation period at 37uC, 5% CO2. Matrix
stiffness was measured using cone and plate rheometry and
quantified in terms of the bulk shear elastic modulus of the
collagen gel G
9
c, which is reported as 104 and 391 Pa for 3D Type
I collagen gels of concentration 2 and 4 mg/mL, respectively, as
described previously [17]. In this manuscript, matrices of modulus
104 Pa are referred to as relatively compliant, while those of
modulus 391 Pa are described as relatively stiff. These elastic
moduli are consistent with those reported previously for non-
cancerous and breast cancer-associated stroma [31]. Three-
dimensional matrices were visualized using a Zeiss Supra 40 VP
scanning electron microscope (see Text S1).
Cell tracking
At the time of experimentation, adherent monolayer cell
cultures were stained with fluorescent Cell Tracker Orange
CMTMR (Molecular Probes) and subsequently detached using
0.05% Trypsin/0.53 mM EDTA (Cellgro, Manassas, VA). For the
3D matrix assay, cells were imaged following a total incubation
period of 6 h within the matrices (see Collagen matrix preparation and
characterization). Time-lapsed image z-stacks of total thickness 120–
150 mm were collected every 10 min for a total of 4 h at a
magnification of 20X using the LSM 5 Live (Carl Zeiss,
Thornwood, NY) (see Fig. S1 C). Z-stack images were collected
at intervals of 1.65 mm, as optimally computed by the LSM
software. For the 2D matrix assay, 2610
5 fluorescently labeled
cells suspended in 1.5 mL of growth media were deposited atop
the coated glass bottom dish and incubated for 6 h prior to
imaging. Time-lapsed image z-stacks of total thickness 25–30 mm
were collected as described for the 3D matrix assay. During
imaging, both 2D and 3D cultures were housed within a
microscope-mounted incubation chamber that was maintained
at 37uC, 5% CO2.
Motility analyses
Following image collection, cell trajectories and extracellular
bead trajectories were generated using the spots detection and
position tracking features of Imaris image analysis software
(Bitplane, St. Paul, MN). Extracellular tracer beads were used to
track overall sample drift during imaging.Cell migration speed S
was calculated as the total cell track length divided by the total
time over which each cell was recorded in the image field of view.
At each time interval, the incremental cell trajectory was corrected
by adjusting for the sample drift (computed as the average
displacement vector of all tracer beads) that occurred during the
same time interval. Thus, sample drift was accounted for and is
not reflected in the reported values of average population cell
speed ,S. and population persistence time P. Population
persistence time was determined by fitting the (adjusted) mean
squared cell displacements ,d
2(t). to the persistent random walk
model [18], Sd2(t)T~2SST
2Pt {P(1{e{t=P)

, where t is the
elapsed time. The average correlation coefficient for the random
walk curve fits was R=0.87. Three-dimensional Windrose plots
display (adjusted) cell tracks for each matrix condition (Fig. 3). Cell
motility assays were performed 3–4 times per 3D matrix per
condition per cell line and twice per cell line for the 2D matrix
architecture. An average total of N=48 cells were imaged per
combination of 3D matrix and cell line, with an average of
M=125 tracer beads imaged per experiment; an average total of
N=61 cells were imaged per cell line for the 2D matrix
architecture, with an average of M=6 tracer beads imaged per
experiment. All calculations were performed using MATLAB.
Supporting Information
Figure S1 Experimental systems utilized for cell motil-
ity assays. (A) Illustration of 2D assay; cells were attached to a
Type I collagen coat embedded with tracer beads. (B) Illustration
of 3D assay; both cells and tracer beads were wholly suspended
within 3D Type I collagen matrices. (C) Maximum intensity
projection of confocal z-stack; mammary epithelial cells (orange)
and 2 mm tracer beads (green) embedded within a 3D Type I
collagen matrix. Tracer beads serve as reference markers to
account for global sample drift.
(TIF)
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